The questions submitted by all receiving competent authorities were the following:
is the chemical diversity of the active substances in authorised rodenticides in the Union adequate to minimise the occurrence of resistance in the target harmful organisms?
for the different intended uses specified in the applications for product renewal [These uses are the ones authorised for biocidal products listed in R4BP and the ones listed in the new applications for renewal.], are alternative authorised biocidal products or non-chemical means of control and prevention methods available?
are these available non-chemical means of control and prevention methods sufficiently effective?
do the alternative authorised biocidal products or non-chemical alternatives present no other significant economic or practical disadvantages?
do the alternative authorised biocidal products or non-chemical alternatives present a significantly lower overall risk for human health, animal health and the environment?
would some anticoagulant active substances contained in rodenticides have a lower overall risk for human health, animal health and the environment than others?